Key terms
About OABI
OmniAb, Inc. operates as a drug discovery company. It focuses on developing human monoclonal and bispecific therapeutic antibodies. Its platform includes the biological intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse. The company was founded on December 14, 2015 and is headquartered in Emeryville, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest OABI news
Yesterday
9:06am ET
Craig-Hallum Reaffirms Their Buy Rating on OmniAb (OABI)
May 14
8:10am ET
Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Green Thumb Industries (OtherGTBIF) and OmniAb (OABI)
May 14
7:06am ET
Benchmark Co. Sticks to Its Buy Rating for OmniAb (OABI)
May 10
8:09am ET
Truist Financial Keeps Their Buy Rating on OmniAb (OABI)
May 10
6:41am ET
RBC Capital Reaffirms Their Buy Rating on OmniAb (OABI)
May 10
6:20am ET
Analysts Offer Insights on Healthcare Companies: ALX Oncology Holdings (ALXO), Lantern Pharma (LTRN) and OmniAb (OABI)
May 09
4:45pm ET
OmniAb reports Q1 EPS (19c), consensus (16c)
May 06
9:08am ET
OmniAb (OABI) Receives a Buy from Craig-Hallum
Apr 30
9:49pm ET
RBC Capital Remains a Buy on OmniAb (OABI)
Apr 08
9:46pm ET
RBC Capital Remains a Buy on OmniAb (OABI)
Apr 03
5:44am ET
Insiders Load Up on These 2 Stocks — Here’s Why You Should Follow
Mar 25
10:25am ET
Craig-Hallum Sticks to Their Buy Rating for OmniAb (OABI)
Mar 24
9:40pm ET
Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN), OmniAb (OABI) and Vericel (VCEL)
Mar 22
7:18am ET
Benchmark Co. Reaffirms Their Buy Rating on OmniAb (OABI)
Mar 21
10:45am ET
OmniAb’s Market Potential and Financial Stability Affirm Buy Rating
Mar 21
9:20am ET
Analysts Offer Insights on Healthcare Companies: OmniAb (OABI) and Apyx Medical (APYX)
Mar 21
7:27am ET
Stifel Nicolaus Sticks to Its Buy Rating for OmniAb (OABI)
Mar 21
7:10am ET
Analysts Offer Insights on Healthcare Companies: Phreesia (PHR) and OmniAb (OABI)
Mar 20
8:55pm ET
OmniAb’s Strategic Growth and Resilience Reinforce Buy Rating Amidst Q4 Revenue Shortfall
Mar 20
4:09pm ET
OmniAb sees FY24 operating expense similar to FY23
Mar 20
4:09pm ET
OmniAb reports Q4 EPS (14c), consensus (15c)
No recent press releases are available for OABI
OABI Financials
Key terms
Ad Feedback
OABI Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
OABI Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
